Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Mar;35(3):587–589. doi: 10.1128/aac.35.3.587

Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin.

G E Kenny 1, F D Cartwright 1
PMCID: PMC245057  PMID: 1903913

Abstract

Mycoplasma pneumoniae (39 strains) was most susceptible to two quinolones, WIN 57273 and sparfloxacin, with MICs for 90% of the strains (MIC90S) of 0.125 and 0.25 micrograms/ml, respectively. It was susceptible to ofloxacin and ciprofloxacin at 2 micrograms/ml and to lomefloxacin and fleroxacin at 4 micrograms/ml. The MIC90 of erythromycin was 0.062 microgram/ml, and that of tetracycline was 1 microgram/ml.

Full text

PDF
587

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ENNY G. E., GRAYSTON J. T. EATON PLEUROPNEUMONIA-LIKE ORGANISM (MYCOPLASMA PNEUMONIAE) COMPLEMENT-FIXING ANTIGEN: EXTRACTION WITH ORGANIC SOLVENTS. J Immunol. 1965 Jul;95:19–25. [PubMed] [Google Scholar]
  2. Felmingham D., Robbins M. J., Baskerville A. J., Sanghrajka M. D., Ridgway G. L., Grüneberg R. N. Comparative in vitro activity of ciprofloxacin and other unrelated antimicrobials against bacterial respiratory tract pathogens. Drugs Exp Clin Res. 1989;15(2):59–62. [PubMed] [Google Scholar]
  3. Foy H. M., Kenny G. E., Cooney M. K., Allan I. D. Long-term epidemiology of infections with Mycoplasma pneumoniae. J Infect Dis. 1979 Jun;139(6):681–687. doi: 10.1093/infdis/139.6.681. [DOI] [PubMed] [Google Scholar]
  4. Hara K., Suyama N., Yamaguchi K., Kohno S., Saito A. Activity of macrolides against organisms responsible for respiratory infection with emphasis on Mycoplasma and Legionella. J Antimicrob Chemother. 1987 Nov;20 (Suppl B):75–80. doi: 10.1093/jac/20.suppl_b.75. [DOI] [PubMed] [Google Scholar]
  5. Jao R. L. Susceptibility of Mycoplasma pneumoniae to 21 antibiotics in vitro. Am J Med Sci. 1967 Jun;253(6):639–650. doi: 10.1097/00000441-196706000-00001. [DOI] [PubMed] [Google Scholar]
  6. Kaatz G. W., Seo S. M. WIN 57273, a new fluoroquinolone with enhanced in vitro activity versus gram-positive pathogens. Antimicrob Agents Chemother. 1990 Jul;34(7):1376–1380. doi: 10.1128/aac.34.7.1376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kenny G. E. Heat-lability and organic solvent-solubility of mycoplasma antigens. Ann N Y Acad Sci. 1967 Jul 28;143(1):676–681. doi: 10.1111/j.1749-6632.1967.tb27713.x. [DOI] [PubMed] [Google Scholar]
  8. Kenny G. E., Hooton T. M., Roberts M. C., Cartwright F. D., Hoyt J. Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method. Antimicrob Agents Chemother. 1989 Jan;33(1):103–107. doi: 10.1128/aac.33.1.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Misu T., Arai S., Furukawa M., Yamamoto Y., Miyazaki T. Effects of rokitamycin and other macrolide antibiotics on Mycoplasma pneumoniae in L cells. Antimicrob Agents Chemother. 1987 Nov;31(11):1843–1845. doi: 10.1128/aac.31.11.1843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mårdh P. A. Human respiratory tract infections with mycoplasmas and their in vitro susceptibility to tetracyclines and some other antibiotics. Chemotherapy. 1975;21 (Suppl 1):47–57. doi: 10.1159/000221891. [DOI] [PubMed] [Google Scholar]
  11. Nakamura S., Minami A., Nakata K., Kurobe N., Kouno K., Sakaguchi Y., Kashimoto S., Yoshida H., Kojima T., Ohue T. In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone. Antimicrob Agents Chemother. 1989 Aug;33(8):1167–1173. doi: 10.1128/aac.33.8.1167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Niitu Y., Hasegawa S., Suetake T., Kubota H., Komatsu S., Horikawa M. Resistance of Mycoplasma pneumoniae to erythromycin and other antibiotics. J Pediatr. 1970 Mar;76(3):438–443. doi: 10.1016/s0022-3476(70)80485-1. [DOI] [PubMed] [Google Scholar]
  13. Niitu Y., Kubota H., Hasegawa S., Komatsu S., Horikawa M. Susceptibility of Mycoplasma pneumoniae to antibiotics in vitro. Jpn J Microbiol. 1974 Mar;18(2):149–155. doi: 10.1111/j.1348-0421.1974.tb00803.x. [DOI] [PubMed] [Google Scholar]
  14. Osada Y., Ogawa H. Antimycoplasmal activity of ofloxacin (DL-8280). Antimicrob Agents Chemother. 1983 Mar;23(3):509–511. doi: 10.1128/aac.23.3.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Renaudin H., Quentin C., de Barbeyrac B., Bebear C. Activité in vitro de nouvelles quinolones sur les mycoplasmes pathogènes pour l'homme. Pathol Biol (Paris) 1988 May;36(5):496–499. [PubMed] [Google Scholar]
  16. Rylander M., Hallander H. O. In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum. Scand J Infect Dis Suppl. 1988;53:12–17. [PubMed] [Google Scholar]
  17. Shames J. M., George R. B., Holliday W. B., Rasch J. R., Mogabgab W. J. Comparison of antibiotics in the treatment of mycoplasmal pneumonia. Arch Intern Med. 1970 Apr;125(4):680–684. [PubMed] [Google Scholar]
  18. Slotkin R. I., Clyde W. A., Jr, Denny F. W. The effect of antibiotics on Mycoplasma pneumoniae in vitro and in vivo. Am J Epidemiol. 1967 Jul;86(1):225–237. doi: 10.1093/oxfordjournals.aje.a120727. [DOI] [PubMed] [Google Scholar]
  19. Vu A. C., Foy H. M., Cartwright F. D., Kenny G. E. The principal protein antigens of isolates of Mycoplasma pneumoniae as measured by levels of immunoglobulin G in human serum are stable in strains collected over a 10-year period. Infect Immun. 1987 Aug;55(8):1830–1836. doi: 10.1128/iai.55.8.1830-1836.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Waites K. B., Cassell G. H., Canupp K. C., Fernandes P. B. In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones. Antimicrob Agents Chemother. 1988 Oct;32(10):1500–1502. doi: 10.1128/aac.32.10.1500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wolfson J. S., Hooper D. C. Fluoroquinolone antimicrobial agents. Clin Microbiol Rev. 1989 Oct;2(4):378–424. doi: 10.1128/cmr.2.4.378. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES